Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acta Minerals is a biotechnology and nutraceutical company focused on the development and commercialization of specialized mineral-based health products. The company leverages unique mineral formulations designed to address systemic inflammation, oxidative stress, and metabolic health. Their primary focus is on the therapeutic application of humic and fulvic acid complexes, which are marketed for their ability to enhance nutrient absorption and support cellular detoxification. Acta Minerals positions its products as high-purity, science-backed supplements intended for both general wellness and targeted health support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acta Minerals.